Medscape

New Trial Suggests CV Benefit With EPA: RESPECT-EPA

A new Japanese study of highly purified eicosapentaenoic acid (EPA; icosapent ethyl) has suggested a possible benefit in reducing adverse cardiovascular events in patients with chronic coronary artery ...
Healio

Icosapent ethyl ‘could have relevance’ for lowering CV risk in adults with CAD on statins

Please provide your email address to receive an email when new articles are posted on . In patients with CAD and low EPA:AA ratio on a statin, icosapent ethyl reduced coronary events. CV events were ...
MedPage Today

Icosapent Ethyl Linked to Reduced Risk of Cardiovascular Events

Use of icosapent ethyl (Vascepa), a highly purified eicosapentaenoic acid (EPA), may be associated with a reduction in risk of adverse cardiovascular events in Japanese patients with chronic coronary ...
Healio

‘Possible’ benefit with highly purified EPA to reduce CV risk in CAD with statin therapy

Please provide your email address to receive an email when new articles are posted on . CHICAGO — In Japanese adults with chronic CAD already treated with statin therapy, highly purified ...
TCTMD

RESPECT-EPA: Missed Primary Endpoint but Hints of Benefit With Icosapent Ethyl

Photo Credit: AHA/Todd Buchanan 2022. Used with permission. CHICAGO, IL—When added to statin therapy, icosapent ethyl, a pharmaceutical-grade omega-3 fatty acid formulation, did not reduce major ...